Anterior uveitis following combined vaccination for measles, mumps and rubella (MMR): a report of two cases.
OBJECTIVE
To describe two children who developed anterior uveitis after vaccination for common childhood diseases.


METHODS
A retrospective study of two Saudi patients who were seen at The Eye Center, Riyadh, Saudi Arabia.


RESULTS
Aged 12 and 14, respectively, the two patients developed anterior non-granulomatous uveitis 6 and 4 weeks after having the combined vaccination for measles, mumps and rubella (MMR). No other definite cause of uveitis was detected from history or from laboratory work up. Both patients responded to traditional regimens of uveitis therapy. However, they required a treatment period of several months.


CONCLUSIONS
Anterior uveitis may occur following MMR vaccination. Cases of vaccination thus require ophthalmic awareness if visual symptoms or a painful red eye develop.
Islam
S M
SM
The Eye Center and The Eye Foundation for Research in Ophthalmology, Riyadh, Saudi Arabia.
El-Sheikh
H F
HF
Tabbara
K F
KF
D000287:Administration, Topical; D000293:Adolescent; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D002648:Child; D004359:Drug Therapy, Combination; D005260:Female; D005938:Glucocorticoids; D006801:Humans; D007429:Intraocular Pressure; D008297:Male; D022542:Measles-Mumps-Rubella Vaccine / Q000009:adverse effects*; D009184:Mydriatics / Q000627:therapeutic use; D012189:Retrospective Studies; D014606:Uveitis, Anterior / Q000188:drug therapy / Q000209:etiology*; D014611:Vaccination / Q000009:adverse effects*
D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D005938:Glucocorticoids; D022542:Measles-Mumps-Rubella Vaccine; D009184:Mydriatics